Naider Avi Z.

CIK 00016122171 companySTAMFORD, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001612217

Recent Transactions

23 trades

Disposition to Issuer
Loxo Oncology, Inc.
Common Stock
2019-02-15$235.00/sh−111,843→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−15,625→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−11,000→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−8,750→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−7,812→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−7,812→ 0 total
Gift
Loxo Oncology, Inc.
Common Stock
2019-01-31−15,000→ 111,843 total
Purchase
Loxo Oncology, Inc.
Common Stock
2018-12-13$138.92/sh+725→ 126,843 total
Award
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2018-06-13+8,750→ 8,750 total
Gift
Loxo Oncology, Inc.
Common Stock
2018-01-22−3,000→ 141,118 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-01-22$100.00/sh−15,000→ 126,118 total
Sale
Loxo Oncology, Inc.
Common Stock
2017-10-16$90.00/sh−5,000→ 144,118 total
Sale
Loxo Oncology, Inc.
Common Stock
2017-09-18$90.00/sh−5,000→ 149,118 total
Sale
Loxo Oncology, Inc.
Common Stock
2017-09-13$90.00/sh−5,000→ 154,118 total
Award
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2017-06-22+11,000→ 11,000 total
Award
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2016-06-10+7,812→ 7,812 total
Purchase
Loxo Oncology, Inc.
Common Stock
2015-11-17$26.50/sh+3,773→ 159,118 total
Award
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2015-07-28+7,812→ 7,812 total
Conversion
Loxo Oncology, Inc.
Series A Convertible Preferred Stock
2014-08-06−62,499→ 0 total
Conversion
Loxo Oncology, Inc.
Common Stock
2014-08-06+76,017→ 151,499 total
Purchase
Loxo Oncology, Inc.
Common Stock
2014-08-06$13.00/sh+3,846→ 155,345 total
Conversion
Loxo Oncology, Inc.
Series B Convertible Preferred Stock
2014-08-05−13,518→ 0 total
Award
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2014-07-31+15,625→ 15,625 total

Companies

Loxo Oncology, Inc.
Director

Recent Filings

Address

C/O LOXO ONCOLOGY, INC. ONE LANDMARK SQUARE, SUITE 1122

STAMFORD, CT, 06901

View on SEC.gov